Psoriasis remission after gastric bypass surgery: a case report
DOI:
https://doi.org/10.7175/cmi.v8i1.898Keywords:
Psoriasis, Gastric Bypass Surgery, ObesityAbstract
Case reports suggest that gastric bypass surgery in patients with psoriasis may result in complete remission of the disease. A substantial weight loss is achieved in the months following surgery, which is likely to reduce psoriasis symptoms and risk of comorbidities. A 50-year-old man was followed in our Department for several years. He had severe plaque psoriasis requiring superpotent topical steroids and methotrexate. His medical history included morbid obesity (138 kg), dyslipidemia , hypertension and positive family history for psoriasis. He underwent gastric bypass surgery on November 2011. Eight months later, his weight decreased to 86 kg, and he noted a marked improvement in his psoriasis, with reduction of body surface area involvement. In our opinion weight loss may be a useful adjunctive therapy for obese patients with psoriasis.
References
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496-509; http://dx.doi.org/10.1056/NEJMra0804595
Faurschou A, Zachariae C, SkovL et al. Gastric bypass surgery :Improving psoriasi through a GLP-1dependent mechanism? Medical hypotheses 2011; 77: 1098-101; http://dx.doi.org/10.1016/j.mehy.2011.09.011
Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose express of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 1993; 259: 87-91; http://dx.doi.org/10.1126/science.7678183
Dandona P, Weinstock R, Thusu K, et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998; 83:2907-10; http://dx.doi.org/10.1210/jc.83.8.2907; http://dx.doi.org/10.1210/jcem.83.8.5026
Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14: 1132-4; http://dx.doi.org/10.1381/0960892041975569
Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2011; 65: 198-200; http://dx.doi.org/10.1016/j.jaad.2010.01.001
Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking onpsoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34; http://dx.doi.org/10.1001/archderm.141.12.1527
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome [comment]. Lancet 2005; 365: 1415-28; http://dx.doi.org/10.1016/S0140-6736(05)66378-7
Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 859-62; http://dx.doi.org/10.1210/jc.83.3.859; http://dx.doi.org/10.1210/jcem.83.3.4618
Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15; http://dx.doi.org/10.1172/JCI117936
Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008;144:1571-5; http://dx.doi.org/10.1001/archderm.144.12.1571
Hamminga EA, Van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-73; http://dx.doi.org/10.1016/j.mehy.2005.11.050
Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005; 174: 6820-8
Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5; http://dx.doi.org/10.1056/NEJM199602013340503
Wang Y, Chen J, Zhao Y, et al. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol 2008; 158: 1134-5; http://dx.doi.org/10.1111/j.1365-2133.2008.08456.x
Takahashi H, Tsuji H, Takahashi I, et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 2008; 159: 1207-8
Cerman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6; http://dx.doi.org/10.1111/j.1365-2133.2008.08742.x
Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipo insular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005; 15: 692-9; http://dx.doi.org/10.1381/0960892053923789
Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901; http://dx.doi.org/10.1038/29795
Santos-Alvarez J, Goberna R, Sanchez, et al. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6-11; http://dx.doi.org/10.1006/cimm.1999.1490
American Academy of Dermatology Work Group, Menter A, Korman NJ, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65: 137-74; http://dx.doi.org/10.1016/j.jaad.2010.11.055
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)